AMY NELSON: Open Payments
NPI 1265480818 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,681 in 129 payments from 17 companies in 2025. Trend: 2023 $4,266 · 2024 $4,926 · 2025 $2,681
Food & beverage: $2,006Consulting: $600Education: $75
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 8 | $631 |
| Janssen Biotech, Inc. | 27 | $535 |
| ABBVIE INC. | 24 | $419 |
| UCB, Inc. | 22 | $269 |
| Galderma Laboratories, L.P. | 17 | $161 |
| Lilly USA, LLC | 6 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $75 |
| PFIZER INC. | 3 | $62 |
| Amgen Inc. | 3 | $57 |
Products named: Zoryve, TREMFYA, Bimzelx, SKYRIZI, RINVOQ, NEMLUVIO, EBGLYSS, OTEZLA.
Industry payments across WA — which companies pay providers there.
